158 related articles for article (PubMed ID: 37402091)
21. Rapid progression to glioblastoma in a subset of IDH-mutated astrocytomas: a genome-wide analysis.
Richardson TE; Snuderl M; Serrano J; Karajannis MA; Heguy A; Oliver D; Raisanen JM; Maher EA; Pan E; Barnett S; Cai C; Habib AA; Bachoo RM; Hatanpaa KJ
J Neurooncol; 2017 May; 133(1):183-192. PubMed ID: 28421459
[TBL] [Abstract][Full Text] [Related]
22. [The inhibitory effects of corticosteroid on the proliferation of tumor cells derived from human astrocytoma-gliobastoma--with special reference to combined vasopressin--corticosteroid therapy (author's transl)].
Kajikawa H
No Shinkei Geka; 1975 Jan; 3(1):51-6. PubMed ID: 1238914
[TBL] [Abstract][Full Text] [Related]
23. Progression-associated genes in astrocytoma identified by novel microarray gene expression data reanalysis.
MacDonald TJ; Pollack IF; Okada H; Bhattacharya S; Lyons-Weiler J
Methods Mol Biol; 2007; 377():203-22. PubMed ID: 17634619
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic implications of interferon regulatory factor (IRF)-1 and IRF-2 in diffusely infiltrating astrocytomas (DIA): response to interferon (IFN)-beta in glioblastoma cells and prognostic value for DIA.
Yoshino A; Katayama Y; Yokoyama T; Watanabe T; Ogino A; Ota T; Komine C; Fukushima T; Kusama K
J Neurooncol; 2005 Sep; 74(3):249-60. PubMed ID: 16187022
[TBL] [Abstract][Full Text] [Related]
25. Chemotherapy for spinal cord astrocytoma: can natural history be modified?
Lowis SP; Pizer BL; Coakham H; Nelson RJ; Bouffet E
Childs Nerv Syst; 1998 Jul; 14(7):317-21. PubMed ID: 9726582
[TBL] [Abstract][Full Text] [Related]
26. KRN8602 (MX2-hydrochloride): an active new agent for the treatment of recurrent high-grade glioma.
Clarke K; Basser RL; Underhill C; Mitchell P; Bartlett J; Cher L; Findlay M; Dalley D; Pell M; Byrne M; Geldard H; Hill JS; Maher D; Fox RM; Green MD; Kaye AH
J Clin Oncol; 1999 Aug; 17(8):2579-84. PubMed ID: 10561325
[TBL] [Abstract][Full Text] [Related]
27. T2 mapping of the peritumoral infiltration zone of glioblastoma and anaplastic astrocytoma.
Auer TA; Kern M; Fehrenbach U; Tanyldizi Y; Misch M; Wiener E
Neuroradiol J; 2021 Oct; 34(5):392-400. PubMed ID: 33573473
[TBL] [Abstract][Full Text] [Related]
28. Elevated HLA-E levels in human glioblastomas but not in grade I to III astrocytomas correlate with infiltrating CD8+ cells.
Mittelbronn M; Simon P; Löffler C; Capper D; Bunz B; Harter P; Schlaszus H; Schleich A; Tabatabai G; Goeppert B; Meyermann R; Weller M; Wischhusen J
J Neuroimmunol; 2007 Sep; 189(1-2):50-8. PubMed ID: 17675252
[TBL] [Abstract][Full Text] [Related]
29. A Phase II trial of paclitaxel and topotecan with filgrastim in patients with recurrent or refractory glioblastoma multiforme or anaplastic astrocytoma.
Pipas JM; Meyer LP; Rhodes CH; Cromwell LD; McDonnell CE; Kingman LS; Rigas JR; Fadul CE
J Neurooncol; 2005 Feb; 71(3):301-5. PubMed ID: 15735921
[TBL] [Abstract][Full Text] [Related]
30. MGMT promoter hypermethylation correlates with a survival benefit from temozolomide in patients with recurrent anaplastic astrocytoma but not glioblastoma.
Sadones J; Michotte A; Veld P; Chaskis C; Sciot R; Menten J; Joossens EJ; Strauven T; D'Hondt LA; Sartenaer D; Califice SF; Bierau K; Svensson C; De Grève J; Neyns B
Eur J Cancer; 2009 Jan; 45(1):146-53. PubMed ID: 18945611
[TBL] [Abstract][Full Text] [Related]
31. Chaperonin-containing tailless complex polypeptide 1 subunit 6A correlates with increased World Health Organization grade, less isocitrate dehydrogenase mutation, and deteriorative survival of astrocytoma patients.
Hu Y; Fu P; Zhao H; Zhang F; Jiang X; Zhao W; Lv P
J Clin Lab Anal; 2021 Sep; 35(9):e23917. PubMed ID: 34312925
[TBL] [Abstract][Full Text] [Related]
32. Salvage chemotherapy in progressive high-grade astrocytoma.
See SJ; Ty A; Wong MC
Ann Acad Med Singap; 2007 May; 36(5):343-6. PubMed ID: 17549281
[TBL] [Abstract][Full Text] [Related]
33. Expression patterns of Wnt signaling component, secreted frizzled‑related protein 3 in astrocytoma and glioblastoma.
Pećina-Šlaus N; Kafka A; Varošanec AM; Marković L; Krsnik Ž; Njirić N; Mrak G
Mol Med Rep; 2016 May; 13(5):4245-51. PubMed ID: 27035837
[TBL] [Abstract][Full Text] [Related]
34. Nuclear Respiratory Factor 1 (NRF1) Transcriptional Activity-Driven Gene Signature Association with Severity of Astrocytoma and Poor Prognosis of Glioblastoma.
Bhawe K; Felty Q; Yoo C; Ehtesham NZ; Hasnain SE; Singh VP; Mohapatra I; Roy D
Mol Neurobiol; 2020 Sep; 57(9):3827-3845. PubMed ID: 32594352
[TBL] [Abstract][Full Text] [Related]
35. The expression level of cannabinoid receptors type 1 and 2 in the different types of astrocytomas.
Hashemi M; Bashi S; Zali A
Mol Biol Rep; 2020 Jul; 47(7):5461-5467. PubMed ID: 32623617
[TBL] [Abstract][Full Text] [Related]
36. Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma.
Santosh V; Arivazhagan A; Sreekanthreddy P; Srinivasan H; Thota B; Srividya MR; Vrinda M; Sridevi S; Shailaja BC; Samuel C; Prasanna KV; Thennarasu K; Balasubramaniam A; Chandramouli BA; Hegde AS; Somasundaram K; Kondaiah P; Rao MR
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1399-408. PubMed ID: 20501753
[TBL] [Abstract][Full Text] [Related]
37. Association of elevated GRP78 expression with increased astrocytoma malignancy via Akt and ERK pathways.
Zhang LH; Yang XL; Zhang X; Cheng JX; Zhang W
Brain Res; 2011 Jan; 1371():23-31. PubMed ID: 21112319
[TBL] [Abstract][Full Text] [Related]
38. Major Histocompatibility Class-I (MHC-I) downregulation in glioblastoma is a poor prognostic factor but not a predictive indicator for treatment failure.
Butt NS; Kurdi M; Fadul MM; Hakamy S; Addas BMJ; Faizo E; Alkhayyat S; Bamaga AK; Alsinani T; Katib Y; Okal F; Maghrabi Y; Sabbagh AJ; Moshref R; Albalawi S; Alkhotani A; Mohammed F; Mulla N; Baeesa S
Pathol Res Pract; 2023 Oct; 250():154816. PubMed ID: 37725880
[TBL] [Abstract][Full Text] [Related]
39. [Expression of stromal cell-derived factor-1 in endometriosis by steroid receptor coactivators on steroid hormone].
Shi X; Xu W; Sun Y; Dai H; Wang X
Zhonghua Fu Chan Ke Za Zhi; 2014 Feb; 49(2):114-9. PubMed ID: 24739643
[TBL] [Abstract][Full Text] [Related]
40. Early induction of angiogenetic signals in gliomas of GFAP-v-src transgenic mice.
Theurillat JP; Hainfellner J; Maddalena A; Weissenberger J; Aguzzi A
Am J Pathol; 1999 Feb; 154(2):581-90. PubMed ID: 10027415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
